Distinct regulation of dengue virus-induced inflammasome activation in human macrophage subsets

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Wu, Ming Fang ^a   Chen, Szu Ting ^a   Hsieh, Shie Liang ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

C type lectin receptor (CLR); CLEC5A; Dengue Virus (DV); Inflammasomes; Inflammatory macrophages (GM M ); Macrophages (M ); Resting macrophages (M M )

Indexed keywords

COLONY STIMULATING FACTOR 1; CRYOPYRIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLAMMASOME; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 23; RANTES; TRANSFORMING GROWTH FACTOR BETA;

CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; HOST PATHOGEN INTERACTION; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH17 CELL; CYTOLOGY; IMMUNOLOGY; MACROPHAGE; METABOLISM; PATHOGENICITY;

DENGUE VIRUS;

CELL DIFFERENTIATION; DENGUE VIRUS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMASOMES; MACROPHAGE ACTIVATION; MACROPHAGES;

EID: 84878632873     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-36     Document Type: Review

References (46)

1. Dengue and severe dengue. World Health Organization, http://www.who.int/ mediacentre/factsheets/fs117/en/ 15577938
2. CLEC5A is critical for dengue-virus-induced lethal disease. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK, Chiou TW, Wong CH, Hsieh SL, Nature 2008 453 672 676 10.1038/nature07013 18496526 (Pubitemid 351769308)
3. Colony-stimulating factors in inflammation and autoimmunity. Hamilton JA, Nat Rev Immunol 2008 8 533 544 10.1038/nri2356 18551128 (Pubitemid 351913679)
4. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Wu MF, Chen ST, Yang AH, Lin WW, Lin YL, Chen NJ, Tsai IS, Li L, Hsieh SL, Blood 2013 121 95 106 10.1182/blood-2012-05-430090 23152543
5. Regulation of inflammasome signaling. Rathinam VA, Vanaja SK, Fitzgerald KA, Nat Immunol 2012 13 333 10.1038/ni.2237 22430786
6. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS, Lancet 2002 360 1831 1837 10.1016/S0140-6736(02)11772-7 12480361 (Pubitemid 35449422)
7. Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages. Friesenhagen J, Boergeling Y, Hrincius E, Ludwig S, Roth J, Viemann D, J Leukoc Biol 2012 92 11 20 10.1189/jlb.0911479 22442495
8. Hematopoietic growth factors. Sieff CA, J Clin Invest 1987 79 1549 1557 10.1172/JCI112988 3034976 (Pubitemid 17121220)
9. Macrophage polarization in metabolic disorders: functions and regulation. Chinetti-Gbaguidi G, Staels B, Curr Opin Lipidol 2011 22 365 372 10.1097/MOL.0b013e32834a77b4 21825981
10. Modulation of macrophage activation and programming in immunity. Liu G, Yang H, J Cell Physiol 2013 228 502 512 10.1002/jcp.24157 22777800
11. Alternative activation of macrophages: mechanism and functions. Gordon S, Martinez FO, Immunity 2010 32 593 604 10.1016/j.immuni.2010.05.007 20510870
12. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Laskin DL, Chem Res Toxicol 2009 22 1376 1385 10.1021/tx900086v 19645497
13. Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse. Wiktor-Jedrzejczak W, Gordon S, Physiol Rev 1996 76 927 947 8874489 (Pubitemid 26346811)
14. Abnormal differentiation of tissue macrophage populations in 'osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor. Naito M, Hayashi S, Yoshida H, Nishikawa S, Shultz LD, Takahashi K, Am J Pathol 1991 139 657 667 1887865
15. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Wiktor-Jedrzejczak W, Ratajczak MZ, Ptasznik A, Sell KW, Ahmed-Ansari A, Ostertag W, Exp Hematol 1992 20 1004 1010 1505635
16. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, Kapp S, Sylvestre V, Stanley ER, Blood 2002 99 111 120 10.1182/blood.V99.1.111 11756160 (Pubitemid 34532972)
17. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR, Proc Natl Acad Sci U S A 1994 91 5592 5596 10.1073/pnas.91.12.5592 8202532 (Pubitemid 24174374)
18. GM-CSF modulates pulmonary resistance to influenza A infection. Sever-Chroneos Z, Murthy A, Davis J, Florence JM, Kurdowska A, Krupa A, Tichelaar JW, White MR, Hartshorn KL, Kobzik L, et al. Antiviral Res 2011 92 319 328 10.1016/j.antiviral.2011.08.022 21925209
19. Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukaemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody. Fixe P, Lorgeot V, Le Meur Y, Coupey L, Heymann D, Godard A, Praloran V, Cytokine 1996 8 586 591 10.1006/cyto.1996.0078 8891440 (Pubitemid 26294549)
20. Granulocyte macrophage-colony stimulating factor (GM-CSF) recruits immune cells to the pancreas and delays STZ-induced diabetes. Krakowski M, Abdelmalik R, Mocnik L, Krahl T, Sarvetnick N, J Pathol 2002 196 103 112 10.1002/path.1013 11748649 (Pubitemid 34071586)
21. Macrophage proinflammatory activation and deactivation: a question of balance. Valledor AF, Comalada M, Santamaria-Babi LF, Lloberas J, Celada A, Adv Immunol 2010 108 1 20 21056727
22. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD, J Immunol 2007 178 5245 5252 17404308 (Pubitemid 46595309)
23. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA, J Leukoc Biol 2009 86 411 421 10.1189/jlb.1108702 19406830
24. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, Scholz GM, Chang MW, Beckman SK, Cook AD, Hamilton JA, J Immunol 2012 188 5752 5765 10.4049/jimmunol.1103426 22547697
25. Sensing and reacting to microbes through the inflammasomes. Franchi L, Munoz-Planillo R, Nunez G, Nat Immunol 2012 13 325 332 10.1038/ni.2231 22430785
26. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. Schmitz N, Kurrer M, Bachmann MF, Kopf M, J Virol 2005 79 6441 6448 10.1128/JVI.79.10.6441-6448.2005 15858027 (Pubitemid 40617247)
27. Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. Sergerie Y, Rivest S, Boivin G, J Infect Dis 2007 196 853 860 10.1086/520094 17703415 (Pubitemid 47378934)
28. Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. Liu B, Mori I, Hossain MJ, Dong L, Takeda K, Kimura Y, J Gen Virol 2004 85 423 428 10.1099/vir.0.19596-0 14769900 (Pubitemid 38262577)
29. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M, J Virol 1999 73 2401 2409 9971824 (Pubitemid 29098146)
30. Inflammasomes and viruses: cellular defence versus viral offence. Gram AM, Frenkel J, Ressing ME, J Gen Virol 2012 93 2063 2075 10.1099/vir.0.042978-0 22739062
31. Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. Chen YC, Wang SY, J Virol 2002 76 9877 9887 10.1128/JVI.76.19.9877-9887.2002 12208965 (Pubitemid 35006527)
32. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. Jessie K, Fong MY, Devi S, Lam SK, Wong KT, J Infect Dis 2004 189 1411 1418 10.1086/383043 15073678 (Pubitemid 38543590)
33. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, McKerrow JH, Beatty PR, Harris E, Am J Trop Med Hyg 2009 80 416 424 19270292
34. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, Lai JH, J Immunol 2001 166 1499 1506 11160189
35. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH, Pro Natl Acad Sci U S A 2004 101 4560 4565 10.1073/pnas.0400983101 (Pubitemid 38437450)
36. Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17. Dungan LS, Mills KH, Cytokine 2011 56 126 132 10.1016/j.cyto.2011. 07.007 21824786
37. The role of inflammasome-derived IL-1 in driving IL-17 responses. Mills KH, Dungan LS, Jones SA, Harris J, J Leukoc Biol 2013 93 489 497 10.1189/jlb.1012543 23271701
38. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. Peral de Castro C, Jones SA, Ni Cheallaigh C, Hearnden CA, Williams L, Winter J, Lavelle EC, Mills KH, Harris J, J Immunol 2012 189 4144 4153 10.4049/jimmunol.1201946 22972933
39. Circulating cytokines as mediators of fever. Netea MG, Kullberg BJ, Van der Meer JW, Clin Infect Dis 2000 31 Suppl 5 178 S184 11113021
40. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. Dinarello CA, J Endotoxin Res 2004 10 201 222 15373964 (Pubitemid 39481010)
41. Induction, function and regulation of IL-17-producing T cells. Mills KH, Eur J Immunol 2008 38 2636 2649 10.1002/eji.200838535 18958872
42. Dengue virus pathogenesis: an integrated view. Martina BE, Koraka P, Osterhaus AD, Clin Microbiol Rev 2009 22 564 581 10.1128/CMR.00035-09 19822889
43. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC, FEMS Immunol Med Microbiol 2001 30 229 233 10.1111/j.1574-695X.2001.tb01575.x 11335143 (Pubitemid 32373298)
44. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF, BMC Infect Dis 2008 8 86 10.1186/1471-2334-8-86 18578883
45. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Ichinohe T, Pang IK, Iwasaki A, Nat Immunol 2010 11 404 410 20383149
46. Emerging inflammasome effector mechanisms. Lamkanfi M, Nat Rev Immunol 2011 11 213 220 10.1038/nri2936 21350580